Complete Range of Anatomical Pathology Products
Epredia was established in July 2019 through an acquisition by PHC Group from Thermo Fisher Scientific. Powered by trusted brands such as Shandon, Microm, Menzel Gläser and Richard-Allan Scientific, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.
Immunohistochemistry (IHC) , Immunocytochemistry (ICC) & Immunofluorescence (IF)
Bio SB has a talented, dedicated, and vibrant team of professionals that excel in the R&D, Production and Marketing of immunochemicals and nucleic acids for Cancer Diagnostics and Research, Microbiology, Immunology and Immunotherapy. Bio SB is a CE/IVDD and ISO 13485:2016 certified company that manufactures and develops products in accordance with USA FDA QSR 21 CFR Part 820 cGMP. These guidelines enable us to produce IVD products that meet the highest in vitro diagnostic standards.
Immunohistochemistry (IHC)
In the past 16 years, Innovex has remained true to its original promise of innovation and quality and it is now serving the field with such revolutionary products such as STAT- Wash Free, Background-Free staining kits, Background-Free Animal IHC products, room tempera- ture stain amplification technologies, Uni-Trieve, FcRe- ceptor Blocker and Background Buster technologies to name a few.
Immunohistochemistry (IHC)
GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical IHC antibodies in-house, making us the first and only institution to date to achieve this.
Immunohistochemistry (IHC) , Immunocytochemistry (ICC) & Immunofluorescence (IF)
Bio SB has a talented, dedicated, and vibrant team of professionals that excel in the R&D, Production and Marketing of immunochemicals and nucleic acids for Cancer Diagnostics and Research, Microbiology, Immunology and Immunotherapy. Bio SB is a CE/IVDD and ISO 13485:2016 certified company that manufactures and develops products in accordance with USA FDA QSR 21 CFR Part 820 cGMP. These guidelines enable us to produce IVD products that meet the highest in vitro diagnostic standards.
Fluorescent in situ Hybridization (FISH) & Chromogenic in situ Hybridization (CISH)
ZytoVision started with a vision to develop and produce innovative in vitro diagnostic products, primarily for tumour diagnosis, based on the technique of in situ hybridization. ZytoVision is based in Bremerhaven, Germany – has been operating successfully in the international market for more than 10 years and is widely regarded as a pioneer in high-quality molecular diagnostic devices.